Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Receivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Camp4 Therapeutics (CAMP) Other Non-Current Liabilities: 2023-2025

Historic Other Non-Current Liabilities for Camp4 Therapeutics (CAMP) over the last 1 years, with Sep 2025 value amounting to $16.7 million.

  • Camp4 Therapeutics' Other Non-Current Liabilities rose 836500.00% to $16.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $16.7 million, marking a year-over-year increase of 836500.00%. This contributed to the annual value of $2,000 for FY2024, which is negligibly% changed negligibly from last year.
  • Latest data reveals that Camp4 Therapeutics reported Other Non-Current Liabilities of $16.7 million as of Q3 2025, which was up 836,500.00% from $2,000 recorded in Q2 2025.
  • Over the past 5 years, Camp4 Therapeutics' Other Non-Current Liabilities peaked at $16.7 million during Q3 2025, and registered a low of $2,000 during Q4 2023.
  • In the last 3 years, Camp4 Therapeutics' Other Non-Current Liabilities had a median value of $2,000 in 2025 and averaged $2.8 million.
  • Data for Camp4 Therapeutics' Other Non-Current Liabilities shows a peak YoY spiked of 836,500.00% (in 2025) over the last 5 years.
  • Camp4 Therapeutics' Other Non-Current Liabilities (Quarterly) stood at $2,000 in 2023, then remained steady at $2,000 in 2024, then skyrocketed by 836,500.00% to $16.7 million in 2025.
  • Its Other Non-Current Liabilities stands at $16.7 million for Q3 2025, versus $2,000 for Q2 2025 and $2,000 for Q1 2025.